NITA HASTINGS: Open Payments
NPI 1255173217 · DRESDEN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 111 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $420 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 36 | $490 |
| Insmed, Inc. | 9 | $206 |
| Verona Pharma, Inc. | 7 | $183 |
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| Merck Sharp & Dohme LLC | 10 | $174 |
| HARMONY BIOSCIENCES LLC | 7 | $171 |
| Regeneron Healthcare Solutions, Inc. | 9 | $165 |
| GENZYME CORPORATION | 6 | $94 |
| Viatris Specialty LLC | 5 | $87 |
| United Therapeutics Corporation | 4 | $73 |
Products named: NUCALA, DUPIXENT, TRELEGY ELLIPTA, Arikayce, Ohtuvayre, WINREVAIR, WAKIX, FASENRA.
Industry payments across TN — which companies pay providers there.
